In a report released yesterday, William Quirk from Piper Jaffray reiterated a Hold rating on Fulgent Genetics Inc (NASDAQ: FLGT), with a price target of $5.10. The company’s shares closed yesterday at $4.86.
According to TipRanks.com, Quirk is a 5-star analyst with an average return of 18.5% and a 69.5% success rate. Quirk covers the Healthcare sector, focusing on stocks such as Accelerate Diagnostics, Pacific Biosciences, and Idexx Laboratories.
The word on The Street in general, suggests a Hold analyst consensus rating for Fulgent Genetics Inc with a $5.10 average price target.
See today’s analyst top recommended stocks >>
Based on Fulgent Genetics Inc’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $1.91 million. In comparison, last year the company had a GAAP net loss of $25K.
Based on the recent corporate insider activity of 9 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care.
